T he annual Hajj pilgrimage brings >2.5 million pilgrims from >160 countries to Mecca and Medina in Saudi Arabia during a 1-week period (1) . In the past, 6.0%-9.8% of Hajj pilgrims with acute respiratory tract infection have been found to have infl uenza (2) (3) (4) . Seasonal infl uenza vaccine is recommended for pilgrims by Saudi Arabia's Ministry of Health (5), but vaccination coverage has been low (4, 6) .
The Study
The Hajj occurs during the twelfth month of the Islamic calendar, a lunar calendar that shifts 11 The survey was conducted by a team of 2 epidemiologists, 2 health workers, and 2 laboratory technicians from the Preventive Sector, Egyptian Ministry of Health, during the peak return period. Every tenth pilgrim on the ship from Jeddah arriving at Port Tawfi q on December 14, 2009, was selected for the survey sample without regard to illness status. At Cairo International Airport, pilgrims were selected from among all pilgrims on the 9 fl ights from Jeddah arriving during 9 AM-9 PM on December 10-12, 2009. Because the survey was conducted at the baggage-claim area, probability sampling proved to be diffi cult. With instructions to choose pilgrims throughout the area around the carousel without regard to age, sex, or illness status, the team selected a convenience sample of ≈50 pilgrims from each fl ight.
After providing verbal consent, pilgrims were asked their age, in which governorate they lived, and whether they had been vaccinated against pandemic (H1N1) 2009 virus. Their oropharynx was then swabbed, and swab specimens were placed in viral transport medium and kept in liquid nitrogen until transfer to the Ministry of Health's Central Public Health Laboratory. All specimens were tested at the US Naval Medical Research Unit No Results were weighted according to probabilities of selection within the ship and each plane, which were considered separate strata. Data were analyzed with PROC SURVEYFREQ in SAS version 9.1 (SAS Institute Inc., Cary, NC, USA).
In all, 559 pilgrims were selected for the survey sample. Seven pilgrims refused to participate, and interview data were missing for 1 pilgrim, leaving 551 pilgrims in the analysis: 206 pilgrims from 4 fl ights on December 10, 219 pilgrims from 5 fl ights on December 12, and 126 pilgrims from the ship arriving December 14. The stated age of 549 (99.6%) of pilgrims in the sample was in the allowed age range of 12-65 years. Most were from the Cairo metropolitan area (43.8%) or Lower Egypt (51.0%); these areas were overrepresented compared with the proportion of the national population living in them (Table) (12) , and to our knowledge, few countries required predeparture vaccination against it. Thus, we expect that pilgrims were exposed to this virus during the Hajj, but the extent of exposure is uncertain. The only data of which we are aware that have been released thus far on the extent of such exposure were provided by the Minister of Health, Saudi Arabia, who announced on the last day of the Hajj that pandemic (H1N1) 2009 had been diagnosed in only 73 persons during the Hajj (5 of whom died) (13). Haworth et al. have argued that a much larger number of cases is likely, on the basis of the expected case-fatality ratio among the Hajj pilgrims and on modeling results (14) .
Our survey had several limitations. First, the results may not apply to pilgrims who returned to Egypt before or after the survey period. Second, pilgrims from Upper Egypt and coastal Egypt were underrepresented in the survey sample. Third, convenience sampling was used to select pilgrims arriving by plane. Fourth, unvaccinated pilgrims may have been reluctant to tell interviewers they had not been vaccinated because predeparture vaccination was required. Finally, some pilgrims may have been infected with pandemic (H1N1) 2009 virus shortly before swab samples were obtained but were not yet shedding virus.
Conclusions
Egypt demonstrated that it could implement a predeparture vaccination requirement despite late arrival of the vaccine, and our survey found no evidence that pilgrims returned to Egypt with pandemic (H1N1) 2009 virus infection during the peak return period. These results may prompt other countries to consider a similar infl uenza vaccination policy before the Hajj and other mass gatherings where amplifi cation of infl uenza virus transmission is a major threat. Studies of vaccine effectiveness, costeffectiveness, and cost-benefi t in these settings would provide additional useful information. (11) . The areas were formed by grouping Egypt's governorates as follows: Coastal Egypt: Alexandria, Damietta, Ismailia, Matrouh, North Sinai, PortSaid, Suez, Red Sea; Lower Egypt: Behera, Dakahlia, Gharbia, KafrElSheikh, Menoufia, Sharkia; Cairo metropolitan area: Cairo, Giza, Kalyoubia; Upper Egypt: Aswan, Asyout, Beni-Suef, ElWadi ElGidid, Fayoum, Helwan, Luxor City, Menia, Qena, South Sinai, Suhag, and 6th October. ‡By real-time reverse transcription PCR testing.
